Skip to main content
Uterine Cervical NeoplasmsBehavioral

What this study is

This study is testing a new way to help people who are unhoused get screened for cervical cancer. Cervical cancer can often be prevented if it is found early. Many people who lack stable housing usually do not receive regular screenings.

Through this project, the investigators will bring screening to community locations in Tucson, Arizona, using a mobile health unit (MHU) from the University of Arizona (UA) and El Rio Health. At these sites, participants will receive easy-to-understand education about cervical cancer, learn how to collect their own sample for human papillomavirus (HPV) testing, and get follow-up care if needed.

The study has two goals:

  • First, the investigators will see if this community-based approach helps more people complete cervical cancer screening.
  • Second, the investigators will ask participants, clinicians, and outreach staff for their opinions about the program and its practicality and acceptability.

By testing this approach, the investigators hope to find a way to make cervical cancer screening more accessible and effective for unhoused individuals.

What's being tested

  • Human papillomavirus Self-collection

    Intervention · OTHER

    The individual will receive both verbal instruction on self-collection from trained health educators in the mobile health unit, as well as adapted educational materials on human papillomavirus self-collection and information about follow-up care in the case of abnormal results. Individuals will be provided with a safe and private space in the Mobile Health Unit to self-collect.

  • Usual Care

    Intervention · OTHER

    Usual care, will involve reminders about overdue Cervical Cancer screening and support with scheduling clinic appointments for screening, arranging for transportation, and addressing other barriers to attendance

Study details

Official title
Human Papillomavirus Self-Sampling Options to Promote Equity (HOPE)
Sponsor
University of Arizona
Conditions
Uterine Cervical Neoplasms · HPV Testing · Pap Smear
Enrolling
100 people
Starts
2026-08-01
Est. completion
2027-05-31
Design
Open-label, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗